BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 20565469)

  • 1. Follow-up of probably benign lesions (BI-RADS 3 category) in breast MR imaging.
    Hauth E; Umutlu L; Kümmel S; Kimmig R; Forsting M
    Breast J; 2010; 16(3):297-304. PubMed ID: 20565469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MR imaging in probably benign lesions (BI-RADS category 3) of the breast.
    Gökalp G; Topal U
    Eur J Radiol; 2006 Mar; 57(3):436-44. PubMed ID: 16316732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer yield of probably benign breast MR examinations.
    Eby PR; Demartini WB; Peacock S; Rosen EL; Lauro B; Lehman CD
    J Magn Reson Imaging; 2007 Oct; 26(4):950-5. PubMed ID: 17896380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative 2- and 3-dimensional analysis of pharmacokinetic model-derived variables for breast lesions in dynamic, contrast-enhanced MR mammography.
    Hauth EA; Jaeger HJ; Maderwald S; Muehler A; Kimmig R; Forsting M
    Eur J Radiol; 2008 May; 66(2):300-8. PubMed ID: 17658235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of malignancy in lesions classified as probably benign after dynamic contrast-enhanced breast MRI examination.
    Sadowski EA; Kelcz F
    J Magn Reson Imaging; 2005 May; 21(5):556-64. PubMed ID: 15834907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of initially only magnetic resonance mammography-detected findings with and without correlate at second-look sonography: distribution according to patient history of breast cancer and lesion size.
    Linda A; Zuiani C; Londero V; Bazzocchi M
    Breast; 2008 Feb; 17(1):51-7. PubMed ID: 17709249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probably benign lesions detected on breast MR imaging.
    Eby PR; DeMartini WB; Gutierrez RL; Lehman CD
    Magn Reson Imaging Clin N Am; 2010 May; 18(2):309-21, x. PubMed ID: 20494314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probably benign lesions at breast magnetic resonance imaging: preliminary experience in high-risk women.
    Liberman L; Morris EA; Benton CL; Abramson AF; Dershaw DD
    Cancer; 2003 Jul; 98(2):377-88. PubMed ID: 12872360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnostic value of a breast MRI score for the prediction of malignancy of breast lesions detected solely with MRI].
    Siegmann KC; Moron HU; Baur A; Hahn M; Vogel U; Claussen CD; Bitzer M
    Rofo; 2009 Jun; 181(6):556-63. PubMed ID: 19452398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced mass on contrast-enhanced breast MR imaging: Lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images.
    Yabuuchi H; Matsuo Y; Okafuji T; Kamitani T; Soeda H; Setoguchi T; Sakai S; Hatakenaka M; Kubo M; Sadanaga N; Yamamoto H; Honda H
    J Magn Reson Imaging; 2008 Nov; 28(5):1157-65. PubMed ID: 18972357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of probably benign breast MRI lesions.
    Eby PR; DeMartini WB; Gutierrez RL; Saini MH; Peacock S; Lehman CD
    AJR Am J Roentgenol; 2009 Sep; 193(3):861-7. PubMed ID: 19696303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The challenge of imaging dense breast parenchyma: is magnetic resonance mammography the technique of choice? A comparative study with x-ray mammography and whole-breast ultrasound.
    Pediconi F; Catalano C; Roselli A; Dominelli V; Cagioli S; Karatasiou A; Pronio A; Kirchin MA; Passariello R
    Invest Radiol; 2009 Jul; 44(7):412-21. PubMed ID: 19448554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the three-time-point method for diagnosis of breast lesions in contrast-enhanced MR mammography.
    Hauth EA; Stockamp C; Maderwald S; Mühler A; Kimmig R; Jaeger H; Barkhausen J; Forsting M
    Clin Imaging; 2006; 30(3):160-5. PubMed ID: 16632149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening breast MR imaging: comparison of interpretation of baseline and annual follow-up studies.
    Abramovici G; Mainiero MB
    Radiology; 2011 Apr; 259(1):85-91. PubMed ID: 21285337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histologic work-up of non-palpable breast lesions classified as probably benign at initial mammography and/or ultrasound (BI-RADS category 3).
    Gruber R; Jaromi S; Rudas M; Pfarl G; Riedl CC; Flöry D; Graf O; Sickles EA; Helbich TH
    Eur J Radiol; 2013 Mar; 82(3):398-403. PubMed ID: 22429299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of breast lesions with CE-MR multimodal morphological and kinetic analysis: comparison with conventional mammography and high-resolution ultrasound.
    Vassiou K; Kanavou T; Vlychou M; Poultsidi A; Athanasiou E; Arvanitis DL; Fezoulidis IV
    Eur J Radiol; 2009 Apr; 70(1):69-76. PubMed ID: 18295425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast MRI in the evaluation of locally recurrent or new breast cancer in the postoperative patient: correlation of morphology and enhancement features with the BI-RADS category.
    Seely JM; Nguyen ET; Jaffey J
    Acta Radiol; 2007 Oct; 48(8):838-45. PubMed ID: 17851971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Palpable masses in breast during lactation.
    Obenauer S; Dammert S
    Clin Imaging; 2007; 31(1):1-5. PubMed ID: 17189838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic contrast-enhanced breast MR imaging in men: preliminary results.
    Morakkabati-Spitz N; Schild HH; Leutner CC; von Falkenhausen M; Lutterbey G; Kuhl CK
    Radiology; 2006 Feb; 238(2):438-45. PubMed ID: 16371581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MR imaging-guided 9-gauge vacuum-assisted core-needle breast biopsy: initial experience.
    Orel SG; Rosen M; Mies C; Schnall MD
    Radiology; 2006 Jan; 238(1):54-61. PubMed ID: 16304093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.